Hamad Adel Khalifa Sultan, Haji Jassim
Department of Electrophysiology, Mohammed Bin Khalifa Bin Salman Al Khalifa Cardiac Centre, Awali, Kingdom of Bahrain.
International Group of Artificial Intelligence, Manama, Kingdom of Bahrain.
Curr Cardiol Rev. 2025;21(4):e1573403X334095. doi: 10.2174/011573403X334095241205041550.
At a critical juncture in the ongoing fight against cardiovascular disease (CVD), healthcare professionals are striving for more informed and expedited decisionmaking. Artificial intelligence (AI) promises to be a guiding light in this endeavor. The diagnosis of coronary artery disease has now become non-invasive and convenient, while wearable devices excel at promptly detecting life-threatening arrhythmias and treatments for heart failure.
This study aimed to highlight the applications of AI in cardiology with a particular focus on arrhythmias and its potential impact on healthcare for all through careful implementation and constant research efforts.
An extensive search strategy was implemented. The search was conducted in renowned electronic medical databases, including Medline, PubMed, Cochrane Library, and Google Scholar. Artificial Intelligence, cardiovascular diseases, arrhythmias, machine learning, and convolutional neural networks in cardiology were used as keywords for the search strategy.
A total of 6876 records were retrieved from different electronic databases. Duplicates (N = 1356) were removed, resulting in 5520 records for screening. Based on predefined inclusion and exclusion criteria, 4683 articles were excluded. Following the full-text screening of the remaining 837 articles, a further 637 were excluded. Ultimately, 200 studies were included in this review.
AI represents not just a development but a cutting-edge force propelling the next evolution of cardiology. With its capacity to make precise predictions, facilitate non-invasive diagnosis, and personalize therapies, AI holds the potential to save lives and enhance healthcare quality on a global scale.
在当前抗击心血管疾病(CVD)的关键节点,医疗保健专业人员正在努力做出更明智、更迅速的决策。人工智能(AI)有望成为这一努力中的一盏明灯。冠状动脉疾病的诊断现已变得无创且便捷,而可穿戴设备在及时检测危及生命的心律失常以及心力衰竭治疗方面表现出色。
本研究旨在突出人工智能在心脏病学中的应用,特别关注心律失常,以及通过谨慎实施和持续研究努力,其对全民医疗保健的潜在影响。
实施了广泛的检索策略。检索在著名的电子医学数据库中进行,包括Medline、PubMed、Cochrane图书馆和谷歌学术。将“人工智能”“心血管疾病”“心律失常”“机器学习”和“心脏病学中的卷积神经网络”用作检索策略的关键词。
从不同电子数据库中总共检索到6876条记录。去除重复记录(n = 1356),得到5520条记录用于筛选。根据预定义的纳入和排除标准,排除了4683篇文章。在对其余837篇文章进行全文筛选后,又排除了637篇。最终,本综述纳入了200项研究。
人工智能不仅代表着一种发展,更是推动心脏病学下一次演进的前沿力量。凭借其进行精确预测、促进无创诊断和个性化治疗的能力,人工智能有潜力在全球范围内拯救生命并提高医疗保健质量。